The WACC of Kymera Therapeutics Inc (KYMR) is 7.4%.
| Range | Selected | |
| Cost of equity | 6.50% - 8.40% | 7.45% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 8.50% | 7.75% |
| WACC | 6.5% - 8.4% | 7.4% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.58 | 0.62 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.50% | 8.40% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 7.00% | 8.50% |
| After-tax WACC | 6.5% | 8.4% |
| Selected WACC | 7.4% | |